Arcadia Biosciences (NASDAQ:RKDA) Shares Pass Below Fifty Day Moving Average – What’s Next?

Arcadia Biosciences, Inc. (NASDAQ:RKDAGet Free Report)’s share price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $2.24 and traded as low as $1.8239. Arcadia Biosciences shares last traded at $1.95, with a volume of 15,134 shares.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Arcadia Biosciences in a research note on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Get Our Latest Stock Analysis on Arcadia Biosciences

Arcadia Biosciences Stock Performance

The company has a market capitalization of $3.37 million, a price-to-earnings ratio of 0.77 and a beta of 0.60. The company’s fifty day simple moving average is $2.24 and its two-hundred day simple moving average is $3.25.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.

See Also

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.